Trial Profile

Assessment of beta-blocker treatment in Japanese patients with chronic heart failure.

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 27 Aug 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Carvedilol (Primary)
Indications Chronic heart failure
Focus Pharmacogenomic; Therapeutic Use
Acronyms J-CHF

Most Recent Events

27 Aug 2013 Status changed from completed to discontinued.
21 Apr 2012 Results presented at the 18th World Congress of Cardiology.
17 Nov 2009 Results presented as a late-breaking abstract at the 82nd Annual Scientific Sessions of the American Heart Association.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com